Johnson & Johnson (JNJ.N)
21 Oct 2016
* U.S. Remicade sales rise 9.4 pct (Adds analyst comments, updates shares)
* U.S. Remicade sales rise 9.4 pct (Adds CFO comment, context on Remicade patent battle with Pfizer)
Oct 18 U.S. stock index futures were modestly higher on Tuesday, buoyed by better-than-expected quarterly reports, including from Netflix and Johnson & Johnson.
* Q3 earnings per share view $1.66 -- Thomson Reuters I/B/E/S
Oct 18 Johnson & Johnson reported a 4.2 percent increase in quarterly revenue, fueled by strong sales in its prescription drugs business.
Pfizer Inc said on Monday it will begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices.
Oct 17 Pfizer Inc said on Monday it plans to begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices.
BOSTON (Due to inaccurate data in Fidelity's original filing, this October 5 story corrects to show that Fidelity's venture arm's investment in Adaptimmune rose to $41 million, not $270 million; that Fidelity Select Biotechnology Portfolio paid at least four times more than rivals for shares, not 24 times; and that the venture arm got its Adaptimmune shares for about $3.54 each, not 59 cents each.)
Johnson & Johnson is telling patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin, though it describes the risk as low. | Video
|General Electric Company (GE.N)||$28.98||-0.09|
|Procter & Gamble Co (PG.N)||$84.33||-0.60|
|Pfizer Inc. (PFE.N)||$32.18||-0.36|
|Novartis AG (NOVN.S)||CHF74.90||--|
|Merck & Co., Inc. (MRK.N)||$61.20||-0.72|
|Baxter International Inc (BAX.N)||$48.18||-0.01|
|Stryker Corporation (SYK.N)||$113.71||-0.84|
|Boston Scientific Corporation (BSX.N)||$22.82||-0.19|
|Zimmer Biomet Holdings Inc (ZBH.N)||$127.52||-0.69|